4.6 Review

Survivin - The inconvenient IAP

Journal

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Volume 39, Issue -, Pages 91-96

Publisher

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.semcdb.2014.12.007

Keywords

Survivin; IAP; Cell division; Apoptosis; Cancer; Mitotic catastrophe

Funding

  1. National Institutes of Health (NIH) [P01 CA140043, R01 CA78810, CA190027]

Ask authors/readers for more resources

Although technically a member of the Inhibitor of Apoptosis (IAP) gene family, survivin has consistently defied assumptions, refuted predictions and challenged paradigms. Despite its more than 5500 citations currently in Medline, the biology of survivin has remained fascinatingly complex, its exploitation in human disease, most notably cancer, tantalizing, and its regulation of cellular homeostasis unexpectedly far-reaching. An inconvenient outsider that resists schemes and dogmas, survivin continues to hold great promise to unlock fundamental circuitries of cellular functions in health and disease. (C) 2015 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available